Notes

A news scan found the following headlines: On September 4, 2026, at 6:38:21 PM, Wells Fargo maintained an equal-weight rating on Amgen and raised its price target to $435. At 6:34:18 PM, UBS maintained a buy rating on Teva Pharmaceutical Industries and raised its price target to $48. At 6:30:34 PM, UBS maintained a buy rating on Ermenegildo Zegna and raised its price target to $15.5. At 6:04:34 PM, BNP Paribas maintained an outperform rating on Samsara and raised its price target to $55. At 5:56:45 PM, Goldman Sachs maintained a neutral rating on Imax and raised its price target to $50. At 5:55:44 PM, Goldman Sachs maintained a buy rating on Five Below and raised its price target to $306. At 5:52:15 PM, Roth Capital maintained a buy rating on VersaBank and raised its price target to $28. At 5:50:43 PM, Roth Capital reiterated a buy rating on American Outdoor Brands and raised its price target to $17. At 5:45:12 PM, Roth Capital maintained a buy rating on CrowdStrike Holdings and raised its price target to $220. At 5:42:31 PM, B. Riley Securities reiterated a buy rating on Climb Bio and raised its price target to $30. At 5:37:54 PM, B. Riley Securities maintained a neutral rating on ChargePoint Holdings and raised its price target to $8. At 5:34:33 PM, B. Riley Securities maintained a buy rating on Nutex Health and raised its price target to $325. A news scan found the headline 'SanDisk Jumps 10%, Lululemon Crashes 17%: Stock Market Today' for stocks including ADBE, ADSK, ALAB, AMAT, BTCUSD, COHR, COIN, DIA, EFX, FICO, FIVE, GDX, GWRE, INTC, ITB, IWM, JETS, KIE, KLAC, LULU, MU, PATH, PLTR, QQQ, SMCI, SMTC, SNDK, SNPS, TMUS, TRU, TTMI, VOO, WDAY, WDC, XLC, XLE, XLI, XLK, XLV, XLY, and ZS. At 5:21:58 PM, Piper Sandler maintained a neutral rating on Zscaler and raised its price target to $175. At 5:20:04 PM, Piper Sandler reiterated a neutral rating on Samsara and raised its price target to $46. At 5:18:17 PM, Piper Sandler maintained a neutral rating on Docusign and raised its price target to $75. At 5:14:26 PM, Piper Sandler updated its rating on SFNC.

A data scan found the following cryptocurrency prices and percentages: ETH/USD was last traded at 2447.7315, with a 20-day high of 2565.9000, needing a 4.83% increase for a signal, but no signal was given. LTC/USD was last traded at 50.4408, with a 20-day high of 55.4165, needing a 9.86% increase for a signal, but no signal was given. UNI/USD was last traded at 6.1786, with a 20-day high of 6.4999, needing a 5.20% increase for a signal, but no signal was given. AVAX/USD was last traded at 7.3556, with a 20-day high of 8.3140, needing a 13.03% increase for a signal, but no signal was given. DOGE/USD was last traded at 0.0844, with a 20-day high of 0.1031, needing a 22.20% increase for a signal, but no signal was given. LINK/USD was last traded at 11.6200, with a 20-day high of 12.6734, needing a 9.07% increase for a signal, but no signal was given. SOL/USD was last traded at 101.5655, with a 20-day high of 110.5357, needing an 8.83% increase for a signal, but no signal was given. XRP/USD was last traded at 1.3974, with a 20-day high of 1.7001, needing a 21.66% increase for a signal, but no signal was given. BTC/USD was last traded at 79515.5295, with a 20-day high of 82233.5025, needing a 3.42% increase for a signal, but no signal was given. DOT/USD was last traded at 0.8571, with a 20-day high of 1.0318, needing a 20.38% increase for a signal, but no signal was given.

A news scan found the following headlines: On 2026-09-04T15:59:19Z, Needham Reiterates Buy on Ionis Pharmaceuticals, Maintains $86 Price Target. On 2026-09-04T15:12:41Z, BMO Capital Maintains Market Perform on Ionis Pharmaceuticals, Raises Price Target to $61. On 2026-09-04T14:23:20Z, Ionis Pharmaceuticals Exec Says Zanvastro Will Be Available At List Price Of $285K Per Dose. On 2026-09-04T12:23:39Z, Ionis Drug Wins FDA Approval as First Alexander Disease Treatment. On 2026-09-04T10:29:48Z, HC Wainwright & Co. Reiterates Buy on Ionis Pharmaceuticals, Maintains $115 Price Target. On 2026-09-03T19:56:03Z, FDA Approves Zanvastro For Treatment Of Alexander Disease. On 2026-08-31T10:26:26Z, HC Wainwright & Co. Reiterates Buy on Ionis Pharmaceuticals, Maintains $115 Price Target. On 2026-08-27T14:01:27Z, Citizens Reiterates Market Outperform on Mirum Pharmaceuticals, Maintains $137 Price Target. On 2026-08-20T16:01:25Z, This Allstate Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday, including IONS. On 2026-08-20T12:50:45Z, This Merck Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday, including IONS. On 2026-08-20T11:51:49Z, This Sphere Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday, including IONS. On 2026-08-19T12:52:50Z, This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday, including IONS. On 2026-08-19T11:55:12Z, This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday, including IONS. On 2026-08-19T10:45:21Z, BMO Capital Initiates Coverage On Ionis Pharmaceuticals with Market Perform Rating, Announces Price Target of $60. On 2026-08-18T17:35:20Z, 10 Health Care Stocks Whale Activity In Today’s Session, including IONS.

A news scan found the following stock prices: ELF last price was 107.9, previous close was 107.4, WING last price was 110.275, previous close was 110.15, CELH last price was 31.02, previous close was 31.61, CMG last price was 37.205, previous close was 37.56, and DUOL last price was 155.32, previous close was 158.82. The ELF watch zone is between 90 and 95, which is a potential buy zone if the stock price pulls back. DUOL is being watched for momentum, and CMG, CELH, and WING are being considered for context.

A news scan found the following data: SOL/USD: the last price was 101.1500, the 20-day high was 110.5357, it needs to increase by 9.28% to reach the high, so there is no signal. UNI/USD: the last price was 6.1475, the 20-day high was 6.4999, it needs to increase by 5.73% to reach the high, so there is no signal. XRP/USD: the last price was 1.4053, the 20-day high was 1.7001, it needs to increase by 20.98% to reach the high, so there is no signal. AVAX/USD: the last price was 7.3540, the 20-day high was 8.3140, it needs to increase by 13.05% to reach the high, so there is no signal. BTC/USD: the last price was 79230.3490, the 20-day high was 82233.5025, it needs to increase by 3.79% to reach the high, so there is no signal. DOT/USD: the last price was 0.8525, the 20-day high was 1.0318, it needs to increase by 21.03% to reach the high, so there is no signal. LINK/USD: the last price was 11.5820, the 20-day high was 12.6734, it needs to increase by 9.42% to reach the high, so there is no signal. LTC/USD: the last price was 50.3891, the 20-day high was 55.4165, it needs to increase by 9.98% to reach the high, so there is no signal. DOGE/USD: the last price was 0.0847, the 20-day high was 0.1031, it needs to increase by 21.71% to reach the high, so there is no signal. ETH/USD: the last price was 2445.8575, the 20-day high was 2565.9000, it needs to increase by 4.91% to reach the high, so there is no signal.

A news scan found the following headlines: On 2026-09-04, HC Wainwright & Co. reiterated a buy rating on Ionis Pharmaceuticals, maintaining a $115 price target. On 2026-09-03, the FDA approved Zanvastro for treating Alexander Disease. On 2026-08-31, HC Wainwright & Co. again reiterated a buy rating on Ionis Pharmaceuticals, maintaining a $115 price target. On 2026-08-27, Citizens reiterated a market outperform rating on Mirum Pharmaceuticals, maintaining a $137 price target. On 2026-08-20, an analyst turned bearish on Allstate and others, including Ionis Pharmaceuticals. On the same day, another analyst turned bullish on Merck and others, including Ionis Pharmaceuticals. Also on 2026-08-20, an analyst began coverage of Sphere Entertainment and others, including Ionis Pharmaceuticals, on a bullish note. On 2026-08-19, a Baidu analyst turned bearish, and an Alnylam Pharmaceuticals analyst began coverage on a bullish note, both including Ionis Pharmaceuticals. On the same day, BMO Capital initiated coverage on Ionis Pharmaceuticals with a market perform rating and a $60 price target. On 2026-08-18, there was whale activity in health care stocks, including Ionis Pharmaceuticals. On 2026-08-06, TD Cowen, RBC Capital, and Citizens maintained their buy or outperform ratings on Mirum Pharmaceuticals, lowering their price targets to $140, $135, and $137 respectively. On the same day, HC Wainwright & Co. maintained a buy rating on Mirum Pharmaceuticals, lowering its price target.

A news scan found the following price levels: CMG last price is 37.56, previous close was 38.52, DUOL last price is 158.82, previous close was 157.915, ELF last price is 107.4, previous close was 107.38, and CELH last price is 31.61, previous close was 31.3. Additionally, WING last price is 110.15, previous close was 113.11. The ELF watch zone is between 90 and 95, which is a potential buy zone if the price pulls back. DUOL is being watched for its momentum, which refers to the rate of change in price. CMG, CELH, and WING are being considered in the context of this analysis.

A news scan found the following data: SOL/USD: the last price was 104.1805, the 20-day high was 110.5357, it needs to increase by 6.10% for a signal, but there is no signal. UNI/USD: the last price was 6.4278, the 20-day high was 6.4999, it needs to increase by 1.12% for a signal, but there is no signal. XRP/USD: the last price was 1.4555, the 20-day high was 1.7001, it needs to increase by 16.80% for a signal, but there is no signal. AVAX/USD: the last price was 7.5088, the 20-day high was 8.3140, it needs to increase by 10.72% for a signal, but there is no signal. BTC/USD: the last price was 81077.2070, the 20-day high was 82233.5025, it needs to increase by 1.43% for a signal, but there is no signal. DOT/USD: the last price was 0.8791, the 20-day high was 1.0318, it needs to increase by 17.37% for a signal, but there is no signal. ETH/USD: the last price was 2529.9110, the 20-day high was 2565.9000, it needs to increase by 1.42% for a signal, but there is no signal. LTC/USD: the last price was 51.2972, the 20-day high was 55.4165, it needs to increase by 8.03% for a signal, but there is no signal. DOGE/USD: the last price was 0.0877, the 20-day high was 0.1031, it needs to increase by 17.59% for a signal, but there is no signal. LINK/USD: the last price was 12.0790, the 20-day high was 12.6734, it needs to increase by 4.92% for a signal, but there is no signal.

A news scan found the headline 'FDA Approves Zanvastro For Treatment Of Alexander Disease' for Ionis Pharmaceuticals, or IONS, on 2026-09-03. On 2026-08-31, HC Wainwright & Co. said to buy IONS and set a price target of $115. On 2026-08-27, Citizens said Mirum Pharmaceuticals, or MIRM, is a market outperform and set a price target of $137. A list of downgrades on 2026-08-20 included IONS. A list of upgrades on 2026-08-20 included IONS. A list of initiations on 2026-08-20 included IONS. On 2026-08-19, BMO Capital started covering IONS with a market perform rating and a price target of $60. On 2026-08-06, TD Cowen said to buy MIRM and set a price target of $140. On 2026-08-06, RBC Capital said MIRM is an outperform and set a price target of $135. On 2026-08-06, Citizens said MIRM is a market outperform and set a price target of $137. On 2026-08-06, HC Wainwright & Co. said to buy MIRM and set a price target of $140. On 2026-08-05, Mirum Pharmaceuticals reported a quarterly adjusted earnings per share of $(0.80), which is less than the expected $(0.6).

A news scan found the headline that on 2026-09-04 at 05:26:41Z, Torrid Holdings stock, which is traded under the ticker CURV, went up nearly 13% after the stock market closed. Earlier, at 03:31:17Z on the same day, American Outdoor Brands stock, which is traded under the ticker AOUT, jumped over 25% after hours. On 2026-09-03 at 21:58:48Z, Domo reported its quarterly earnings per share, or EPS, was $(0.21), which is better than the estimated $(0.31), and its sales were $76.783 million, which is less than the estimated $78.056 million.

A news scan found the headline 'PEAD deep-dive question tree, 2026-09-04'. The question is whether a rule to buy US stocks with a high post-earnings announcement drift, or PEAD, which is a measure of how much a stock's price moves after an earnings announcement, can still be used after the next time the market opens. This rule is based on a classic anomaly, or unusual pattern, that has been seen in the past, but has been getting weaker since 2006 and has had some evidence of still working since 2016. The signal to buy is based on a comparison of a company's earnings, guidance, and initial stock price gap, with GAAP SUE, or generally accepted accounting principles surprise, compared to adjusted earnings per share, which is a company's profit divided by the number of shares. The timing of the buy can be as short as seconds or as long as 20 days. The implementation of the rule must consider the costs of buying and selling, the availability of shares to buy, and how many shares can be bought. Further tests are needed to confirm the rule works, including looking at the distribution of stock prices, holding out some data to test the rule, and using statistical methods to validate the results. There are also potential problems to consider, such as selecting the wrong data, not aligning the data with the right time, and ignoring some events. The rule can be applied to different types of stocks, such as large or small companies, US or Chinese companies, and different sectors. The decision to use the rule depends on whether it is likely to work, and what evidence would be needed to revive it if it stops working. In the past, it was likely that the PEAD rule would still work, but weakly, and the least predictable issue was whether a company beating earnings expectations and raising guidance, plus a large gap in the stock price, would lead to the stock price continuing to rise or falling back.

A data scan found the following cryptocurrency prices and percentages: LTC/USD: the last price was 51.1825, the 20-day high was 55.4165, it needs to increase by 8.27% for a signal, which has not happened. BTC/USD: the last price was 81035.5770, the 20-day high was 82233.5025, it needs to increase by 1.48% for a signal, which has not happened. DOGE/USD: the last price was 0.0872, the 20-day high was 0.1031, it needs to increase by 18.34% for a signal, which has not happened. DOT/USD: the last price was 0.8742, the 20-day high was 1.0318, it needs to increase by 18.02% for a signal, which has not happened. SOL/USD: the last price was 103.8720, the 20-day high was 110.5357, it needs to increase by 6.42% for a signal, which has not happened. UNI/USD: the last price was 6.2640, the 20-day high was 6.4999, it needs to increase by 3.77% for a signal, which has not happened. XRP/USD: the last price was 1.4500, the 20-day high was 1.7001, it needs to increase by 17.25% for a signal, which has not happened. AVAX/USD: the last price was 7.4936, the 20-day high was 8.3140, it needs to increase by 10.95% for a signal, which has not happened. ETH/USD: the last price was 2512.2500, the 20-day high was 2565.9000, it needs to increase by 2.14% for a signal, which has not happened. LINK/USD: the last price was 11.9446, the 20-day high was 12.6734, it needs to increase by 6.10% for a signal, which has not happened.

A news scan found the following stock prices: CELH last price was 31.61, previous close was 31.3, CMG last price was 37.56, previous close was 38.52, DUOL last price was 158.82, previous close was 157.915, ELF last price was 107.4, previous close was 107.38, and WING last price was 110.15, previous close was 113.11. The ELF watch zone is between 90 and 95, which is a price range to consider buying if the stock price pulls back. DUOL is being watched for momentum, which refers to the speed of price changes. The context for CMG, CELH, and WING is also being considered.

The operator is currently liquidating and will not open any new positions. The watchlist includes GME on September 8, ADBE on September 10, and KR on September 11, but only to monitor for post-event drift, as the generic pre-event rule failed with a loss of 2.45% based on 3 trades. Oracle was rejected because its investor relations department only provided a mid-September timeline, without a specific date. A review of the FDA's September calendar found no single-drug approval meetings, and a pediatric meeting on September 16 is for postmarketing safety review. A scan of non-US and cryptocurrency sources found no events meeting the criteria. Going forward, biotech entries will require a company-wide catalyst map and stress testing for early FDA actions.

A news scan found the following data: DOT/USD last price is 0.8885, its 20-day high is 1.0318, it needs to increase by 16.12% for a signal, but there is no signal. LINK/USD last price is 11.8254, its 20-day high is 12.6734, it needs to increase by 7.17% for a signal, but there is no signal. SOL/USD last price is 103.6650, its 20-day high is 110.5357, it needs to increase by 6.63% for a signal, but there is no signal. UNI/USD last price is 6.3876, its 20-day high is 6.4999, it needs to increase by 1.76% for a signal, but there is no signal. AVAX/USD last price is 7.5016, its 20-day high is 8.3140, it needs to increase by 10.83% for a signal, but there is no signal. DOGE/USD last price is 0.0874, its 20-day high is 0.1031, it needs to increase by 18.03% for a signal, but there is no signal. ETH/USD last price is 2506.6855, its 20-day high is 2565.9000, it needs to increase by 2.36% for a signal, but there is no signal. LTC/USD last price is 51.3276, its 20-day high is 55.4165, it needs to increase by 7.97% for a signal, but there is no signal. XRP/USD last price is 1.4460, its 20-day high is 1.7001, it needs to increase by 17.57% for a signal, but there is no signal. BTC/USD last price is 81156.1500, its 20-day high is 82233.5025, it needs to increase by 1.33% for a signal, but there is no signal.

A news scan found the following headlines: 2026-09-03T19:56:03Z, the FDA approved Zanvastro for treatment of Alexander Disease for IONS. On 2026-08-31T10:26:26Z, HC Wainwright & Co reiterated a buy rating on Ionis Pharmaceuticals, maintaining a $115 price target. On 2026-08-27T14:01:27Z, Citizens reiterated a market outperform rating on Mirum Pharmaceuticals, maintaining a $137 price target. A list of downgrades for Thursday was published on 2026-08-20T16:01:25Z, including IONS. A list of upgrades for Thursday was published on 2026-08-20T12:50:45Z, including IONS. A list of initiations for Thursday was published on 2026-08-20T11:51:49Z, including IONS. On 2026-08-19T12:52:50Z, a Baidu analyst turned bearish, listing IONS as one of the top 5 downgrades for Wednesday. On 2026-08-19T11:55:12Z, an Alnylam Pharmaceuticals analyst began coverage on a bullish note, listing IONS as one of the top 5 initiations for Wednesday. On 2026-08-19T10:45:21Z, BMO Capital initiated coverage on Ionis Pharmaceuticals with a market perform rating and a $60 price target. A list of health care stocks with whale activity was published on 2026-08-18T17:35:20Z, including IONS. On 2026-08-06T19:52:35Z, TD Cowen maintained a buy rating on Mirum Pharmaceuticals, lowering the price target to $140. On 2026-08-06T17:40:25Z, RBC Capital maintained an outperform rating on Mirum Pharmaceuticals, lowering the price target to $135. On 2026-08-06T13:00:59Z, Citizens maintained a market outperform rating on Mirum Pharmaceuticals, lowering the price target to $137. On 2026-08-06T11:03:59Z, HC Wainwright & Co maintained a buy rating on Mirum Pharmaceuticals, lowering the price target to $140. On 2026-08-05T22:11:45Z, Mirum Pharmaceuticals reported a Q2 adjusted EPS of $(0.80), missing the expected $(0.6).

A news scan found the following stock prices: ELF last price is 107.4, previous close was 107.38, WING last price is 110.15, previous close was 113.11, CELH last price is 31.61, previous close was 31.3, CMG last price is 37.56, previous close was 38.52, and DUOL last price is 158.82, previous close was 157.915. The ELF watch zone is between 90 and 95, which is a potential buy zone if the stock price pulls back. DUOL is being watched for momentum, and CMG, CELH, and WING are being considered for context.

A news scan found the following data: LTC/USD: the last price was 51.7050, the 20-day high was 55.4165, it needs to increase by 7.18% for a signal, but there is no signal. UNI/USD: the last price was 6.3296, the 20-day high was 6.3726, it needs to increase by 0.68% for a signal, but there is no signal. XRP/USD: the last price was 1.4815, the 20-day high was 1.7001, it needs to increase by 14.75% for a signal, but there is no signal. AVAX/USD: the last price was 7.5385, the 20-day high was 8.3140, it needs to increase by 10.29% for a signal, but there is no signal. DOT/USD: the last price was 0.8955, the 20-day high was 1.0318, it needs to increase by 15.22% for a signal, but there is no signal. SOL/USD: the last price was 105.3500, the 20-day high was 110.5357, it needs to increase by 4.92% for a signal, but there is no signal. BTC/USD: the last price was 81552.2970, the 20-day high was 81446.8810, it needs to decrease by 0.13% for a signal, and a breakout was fired. DOGE/USD: the last price was 0.0889, the 20-day high was 0.1031, it needs to increase by 15.98% for a signal, but there is no signal. ETH/USD: the last price was 2510.2290, the 20-day high was 2565.9000, it needs to increase by 2.22% for a signal, but there is no signal. LINK/USD: the last price was 11.8715, the 20-day high was 12.6734, it needs to increase by 6.75% for a signal, but there is no signal.

A news scan found the headline that on 2026-08-31T10:26:26Z, HC Wainwright & Co. reiterated a buy rating on Ionis Pharmaceuticals, which is a company that a financial analyst thinks is a good investment, and maintained a $115 price target, which is the price at which the analyst thinks the stock will trade. On 2026-08-27T14:01:27Z, Citizens reiterated a market outperform rating, which means the analyst thinks the stock will do better than the market, on Mirum Pharmaceuticals and maintained a $137 price target. A news scan found the headline that on 2026-08-20T16:01:25Z, an analyst turned bearish, meaning they think the stock will go down, on Allstate and listed the top 5 downgrades for Thursday, including Ionis Pharmaceuticals. On 2026-08-20T12:50:45Z, an analyst turned bullish, meaning they think the stock will go up, on Merck and listed the top 5 upgrades for Thursday, including Ionis Pharmaceuticals. On 2026-08-20T11:51:49Z, an analyst began coverage, which means they started analyzing the stock, on Sphere Entertainment with a bullish note and listed the top 5 initiations for Thursday, including Ionis Pharmaceuticals. A news scan found the headline that on 2026-08-19T12:52:50Z, an analyst turned bearish on Baidu and listed the top 5 downgrades for Wednesday, including Ionis Pharmaceuticals. On 2026-08-19T11:55:12Z, an analyst began coverage on Alnylam Pharmaceuticals with a bullish note and listed the top 5 initiations for Wednesday, including Ionis Pharmaceuticals. On 2026-08-19T10:45:21Z, BMO Capital initiated coverage on Ionis Pharmaceuticals with a market perform rating, which means the analyst thinks the stock will do as well as the market, and announced a price target of $60. A news scan found the headline that on 2026-08-18T17:35:20Z, there was whale activity, which refers to large investors, in 10 health care stocks, including Ionis Pharmaceuticals. On 2026-08-06T19:52:35Z, TD Cowen maintained a buy rating on Mirum Pharmaceuticals and lowered the price target to $140. On 2026-08-06T17:40:25Z, RBC Capital maintained an outperform rating on Mirum Pharmaceuticals and lowered the price target to $135. On 2026-08-06T13:00:59Z, Citizens maintained a market outperform rating on Mirum Pharmaceuticals and lowered the price target to $137. On 2026-08-06T11:03:59Z, HC Wainwright & Co. maintained a buy rating on Mirum Pharmaceuticals and lowered the price target to $140. A news scan found the headline that on 2026-08-05T22:11:45Z, Mirum Pharmaceuticals reported a Q2 adjusted EPS, which is a measure of profit, of $(0.80), missing the estimate of $(0.68), and sales of $176.243M, beating the estimate of $166.122M.

On September 3, 2026, at 15:00:20, President Trump posted on Truth Social that hundreds of billions of dollars were given to Ukraine and NATO for free, and that Europe would have paid for it if asked. A type of social media platform, Truth Social is where users share posts. At 14:59:10, President Trump posted that the US has a large amount of ammunition, which is weapons, and is producing more munitions, which are types of weapons, at high levels. At 14:19:13, KTLA 5 reported that the Trump administration is trying to get more oil flowing from California. Oil is a type of energy source. At 11:59:52, it was reported that Trump promised cheaper gas, but his team is now blaming Ukraine for high prices. Gas is a type of fuel. At 10:52:05, Scorpio Tankers locked in three-year charters for two vessels, STI Gladiator and STI Jermyn, at daily rates of $40,188 and $42,500, and added an MR tanker, STI Pontiac, to its fleet. A charter is a contract to rent a vessel. At 10:29:32, Israel's Defense Minister Katz said that if Iran attacks Israel, Israel will strike all of Iran's infrastructure, including energy. Infrastructure refers to basic systems and structures. On September 2, 2026, at 17:52:19, it was reported that the US-Iran escalation is the worst since July and is affecting oil and defense ETFs, which are types of investments. At 17:27:38, the White House said that oil from a deal with Venezuela could arrive in the US in November. At 16:57:11, GE Vernova's Roger Martella said that deals with Venezuela will need 1,000 workers. At 14:34:54, it was reported that US gasoline inventories had a 1.173 million barrel draw, which is a decrease in stock. A barrel is a unit of measurement for oil. At 14:33:16, the EIA reported a 0.796 million barrel build in weekly distillates stocks, which is an increase in stock. At 14:31:27, it was reported that US crude oil inventories had a 4.450 million barrel draw. At 14:26:03, Russian Prime Minister Alexander Novak commented on talk of an OPEC+ quota, which is a limit on oil production set by a group of countries.

On September 3, 2026, at 6:29:10 PM, Northland Capital Markets, a company that analyzes stocks, maintained an Outperform rating, which means they think the stock will do better than average, on NetApp, and raised the price target to $187. At 6:25:56 PM, Raymond James, another company that analyzes stocks, maintained an Outperform rating on Haemonetics and raised the price target to $125. At 6:24:51 PM, Raymond James maintained an Outperform rating on Snowflake and raised the price target to $425. At 6:22:29 PM, Raymond James maintained an Outperform rating on CrowdStrike Holdings and raised the price target to $250. At 6:21:42 PM, Raymond James maintained an Outperform rating on Broadcom and raised the price target to $475. At 6:19:43 PM, Raymond James maintained an Outperform rating on Hewlett Packard and raised the price target to $86. At 6:16:56 PM, B. Riley Securities, a company that analyzes stocks, maintained a Buy rating, which means they think the stock is a good investment, on Solana and raised the price target to $3.5. At 6:15:42 PM, B. Riley Securities maintained a Buy rating on Forward Industries and raised the price target to $9. At 6:14:47 PM, B. Riley Securities maintained a Buy rating on BitMine Immersion and raised the price target to $30. At 6:14:06 PM, BTIG, a company that analyzes stocks, maintained a Buy rating on Climb Bio and raised the price target to $32. At 6:13:58 PM, B. Riley Securities maintained a Buy rating on Nakamoto and raised the price target to $11. At 6:12:46 PM, B. Riley Securities maintained a Buy rating on Strategy, also known as MicroStrategy, and raised the price target to $175. At 6:11:06 PM, B. Riley Securities maintained a Buy rating on Strive and raised the price target to $26. At 6:10:01 PM, B. Riley Securities maintained a Buy rating on Atlanticus Holdings and raised the price target to $119. At 6:04:57 PM, BMO Capital, a company that analyzes stocks, maintained an Outperform rating on Netskope and raised the price target to $18. At 6:03:43 PM, BMO Capital maintained an Outperform rating on Chevron and raised the price target to $235. At 6:01:54 PM, Baird, a company that analyzes stocks, maintained an Outperform rating on Climb Bio and raised the price target to $25. At 5:56:25 PM, Roth Capital, a company that analyzes stocks, reiterated, or repeated, a Buy rating on Vox Royalty and raised the price target to $8. At 5:50:39 PM, Roth Capital maintained a Buy rating on Imax and raised the price target.

The automated trading fund manager is watching cryptocurrency prices for a 20-day Donchian breakout, which is a trading strategy that looks for the highest high and lowest low of an asset over a certain period, in this case 20 days. Here are the results: DOT/USD: the last price was 0.8875, the 20-day high was 1.0318, it needs to increase by 16.26% to reach the high, so there is no signal to buy or sell. LINK/USD: the last price was 11.7072, the 20-day high was 12.6734, it needs to increase by 8.25%, so there is no signal. SOL/USD: the last price was 104.3350, the 20-day high was 110.5357, it needs to increase by 5.94%, so there is no signal. UNI/USD: the last price was 6.1498, the 20-day high was 6.3726, it needs to increase by 3.62%, so there is no signal. AVAX/USD: the last price was 7.4930, the 20-day high was 8.3140, it needs to increase by 10.96%, so there is no signal. ETH/USD: the last price was 2501.6700, the 20-day high was 2565.9000, it needs to increase by 2.57%, so there is no signal. LTC/USD: the last price was 51.2000, the 20-day high was 55.4165, it needs to increase by 8.24%, so there is no signal. XRP/USD: the last price was 1.4530, the 20-day high was 1.7001, it needs to increase by 17.00%, so there is no signal. BTC/USD: the last price was 80957.9460, the 20-day high was 81446.8810, it needs to increase by 0.60%, so there is no signal. DOGE/USD: the last price was 0.0889, the 20-day high was 0.1031, it needs to increase by 16.07%, so there is no signal.

We are watching the following stocks for potential pullback entries: CELH, which is currently at $31.205, down from its previous close of $31.3, CMG, which is currently at $37.785, down from its previous close of $38.52, DUOL, which is currently at $158.63, up from its previous close of $157.915, and ELF, which is currently at $105.99, down from its previous close of $107.38. We are also keeping an eye on WING, which is currently at $109.06, down from its previous close of $113.11. For ELF, we have identified a watch zone of $90-95, where we may consider buying if the stock pulls back. We are also monitoring DUOL's momentum, and considering the context of CMG, CELH, and WING.

The fund manager is watching news about Iran and the Hormuz area, which is a strategic waterway for oil tankers, to decide when to exit a trade. On September 3, 2026, at 14:19:13Z, KTLA 5 reported that the Trump administration is trying to increase oil production in California. At 11:59:52Z, a news article said that Trump's team is blaming Ukraine for high gas prices, and economist Paul Krugman thinks they have no way to stop it. At 10:52:05Z, Scorpio Tankers announced that it has rented two large oil tankers, STI Gladiator and STI Jermyn, for three years at daily rates of $40,188 and $42,500, and also added a medium-sized tanker, STI Pontiac, to its fleet. At 10:29:32Z, Israel's Defense Minister Katz said that if Iran attacks Israel, Israel will strike back at all of Iran's infrastructure, including its energy facilities. On September 2, 2026, at 17:52:19Z, there was a report about the worst escalation of tensions between the US and Iran since July, which is affecting oil prices and defense stocks. At 17:27:38Z, the White House said that oil from a deal with Venezuela could arrive in the US in November. At 16:57:11Z, GE Vernova's Roger Martella said that deals with Venezuela will require 1,000 workers. At 14:34:54Z, there was a report that US gasoline inventories decreased by 1.173 million barrels, which is less than the expected decrease of 1.900 million barrels. At 14:33:16Z, the EIA reported that distillates stocks increased by 0.796 million barrels, which is a change from the previous decrease of 2.228 million barrels. At 14:31:27Z, there was a report that US crude oil inventories decreased by 4.450 million barrels, which is more than the expected decrease of 0.400 million barrels. At 14:26:03Z, Russian Prime Minister Alexander Novak said that OPEC+ will not cut oil production right now, because there is a shortage in the market and oil demand is recovering. At 14:04:31Z, it was reported that the OPEC+ meeting on Sunday will not make any decisions about oil output, but will focus on discussing the market. At 13:46:20Z, there was a report that Kalshi will file for US crude oil 'perps', which are a type of financial contract. At 13:13:28Z, US Energy Secretary Wright said that Venezuela's oil production is up 25% and exports are up 50%, and that the US is working to restructure Venezuela's debt. At 13:02:27Z, the fund manager was still watching the situation.